Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy

Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy

Bibliographic Details
Main Authors:	Meng, LQ, Tang, JW, Wang, Y, Zhao, JR, Shang, MY, Zhang, M, Liu, SY, Qu, L, Cai, SQ, Li, XM
Format:	Online
Language:	English
Published:	Blackwell Publishing Ltd 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081123/

Similar Items

Tubulointerstitial disease in diabetic nephropathy
by: Tonolo, Giancarlo, et al.
Published: (2014)

The mechanism of astragaloside IV promoting sciatic nerve regeneration
by: Zhang, Xiaohong, et al.
Published: (2013)

Asiatic acid ameliorates tubulointerstitial fibrosis in mice with ureteral obstruction
by: XU, CHANGGENG, et al.
Published: (2013)

Mefunidone Attenuates Tubulointerstitial Fibrosis in a Rat Model of Unilateral Ureteral Obstruction
by: Liu, Chunyan, et al.
Published: (2015)

Astragaloside IV/lncRNA-TUG1/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats
by: Lei X, et al.
Published: (2018-09-01)

Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress
by: Wang, Zeng Si, et al.
Published: (2015)

Targeting tubulointerstitial remodeling in proteinuric nephropathy in rats
by: Yazdani, Saleh, et al.
Published: (2015)

Astragaloside IV ameliorates renal injury in db/db mice
by: Sun, Huili, et al.
Published: (2016)

Gastroprotective Effects of Astragaloside IV against Acute Gastric Lesion in Rats
by: Mao, Shuai, et al.
Published: (2016)

Protective Effects of Astragaloside IV on db/db Mice with Diabetic Retinopathy
by: Ding, Yuzhi, et al.
Published: (2014)

Delayed treatment with oleanolic acid attenuates tubulointerstitial fibrosis in chronic cyclosporine nephropathy through Nrf2/HO-1 signaling
by: Hong, Yu Ah, et al.
Published: (2014)

CDK5 promotes renal tubulointerstitial fibrosis in diabetic nephropathy via ERK1/2/PPARγ pathway
by: Bai, Xiaoyan, et al.
Published: (2016)

A novel model of adenine-induced tubulointerstitial nephropathy in mice
by: Jia, Ting, et al.
Published: (2013)

Ambulatory blood pressure and tubulointerstitial injury in patients with IgA nephropathy
by: Haruhara, Kotaro, et al.
Published: (2015)

Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes
by: Maezawa, Yoshiro, et al.
Published: (2015)

Hydrogen sulfide inhibits the renal fibrosis of obstructive nephropathy
by: Song, Kai, et al.
Published: (2014)

Calponin Expression in Renal Tubulointerstitial Fibrosis Induced in Rats by Cisplatin
by: Yuasa, Takahiro, et al.
Published: (2014)

Platelet-derived growth factors (PDGFs) in glomerular and tubulointerstitial fibrosis
by: Ostendorf, Tammo, et al.
Published: (2014)

The Hippo-Salvador signaling pathway regulates renal tubulointerstitial fibrosis
by: Seo, Eunjeong, et al.
Published: (2016)

Early Markers of Tubulointerstitial Fibrosis in Children With Idiopathic Nephrotic Syndrome: Preliminary Report
by: Bieniaś, Beata, et al.
Published: (2015)

MicroRNA-130b improves renal tubulointerstitial fibrosis via repression of Snail-induced epithelial-mesenchymal transition in diabetic nephropathy
by: Bai, Xiaoyan, et al.
Published: (2016)

Augmenter of liver regeneration ameliorates renal fibrosis in rats with obstructive nephropathy
by: Chen, Guo-tao, et al.
Published: (2014)

Astragaloside IV Downregulates β-Catenin in Rat Keratinocytes to Counter LiCl-Induced Inhibition of Proliferation and Migration
by: Li, Fu-Lun, et al.
Published: (2012)

Astragaloside IV, a Novel Antioxidant, Prevents Glucose-Induced Podocyte Apoptosis In Vitro and In Vivo
by: Gui, Dingkun, et al.
Published: (2012)

Preventive Effects of a Natural Anti-Inflammatory Agent, Astragaloside IV, on Ischemic Acute Kidney Injury in Rats
by: Tan, Shufeng, et al.
Published: (2013)

Astragaloside IV Attenuates Experimental Autoimmune Encephalomyelitis of Mice by Counteracting Oxidative Stress at Multiple Levels
by: He, Yixin, et al.
Published: (2013)

Therapeutic Effects of Astragaloside IV on Myocardial Injuries: Multi-Target Identification and Network Analysis
by: Zhao, Jing, et al.
Published: (2012)

Protective Effects of Astragaloside IV against Amyloid Beta1-42 Neurotoxicity by Inhibiting the Mitochondrial Permeability Transition Pore Opening
by: Sun, Qinru, et al.
Published: (2014)

Astragaloside IV reduces the expression level of P-glycoprotein in multidrug-resistant human hepatic cancer cell lines
by: WANG, PEI-PEI, et al.
Published: (2014)

Beneficial Effects of Astragaloside IV for Hair Loss via Inhibition of Fas/Fas L-Mediated Apoptotic Signaling
by: Kim, Mi Hye, et al.
Published: (2014)

Effect of astragaloside IV on indoxyl sulfate-induced kidney injury in mice via attenuation of oxidative stress
by: Chunlan Ji, et al.
Published: (2018-09-01)

Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling
by: Fei Xu, et al.
Published: (2018-08-01)

Astragaloside IV Promotes Adult Neurogenesis in Hippocampal Dentate Gyrus of Mouse through CXCL1/CXCR2 Signaling
by: Fei Huang, et al.
Published: (2018-08-01)

Astragaloside IV Attenuates Acetaminophen-Induced Liver Injuries in Mice by Activating the Nrf2 Signaling Pathway
by: Lei Li, et al.
Published: (2018-08-01)

Astragaloside IV ameliorates allergic inflammation by inhibiting key initiating factors in the initial stage of sensitization
by: Bao, Kai-fan, et al.
Published: (2016)

Effect of Astragaloside IV on Neural Stem Cell Transplantation in Alzheimer's Disease Rat Models
by: Haiyan, Hu, et al.
Published: (2016)

Astragaloside IV improves lipid metabolism in obese mice by alleviation of leptin resistance and regulation of thermogenic network
by: Wu, Hui, et al.
Published: (2016)

Beneficial effects of astragaloside IV against angiotensin II-induced mitochondrial dysfunction in rat vascular smooth muscle cells
by: LU, YAO, et al.
Published: (2015)

Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway
by: Liu, Hong-Shuai, et al.
Published: (2016)

Effects of Astragaloside IV on the SDF-1/CXCR4 Expression in Atherosclerosis of apoE−/− Mice Induced by Hyperlipaemia
by: Qin, Hewei, et al.
Published: (2015)